Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your ...

rare genetic skin diseases Top-line results from SELVA, a Phase 3 single-arm, baseline-controlled trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of ...

Researchers developed and used a novel blood test to diagnose and successfully treat a patient with a rare form of a severe ...

The mission of the Skin Diseases Research Center (SDRC) is to add value to our investigators through strength of focus on uniting basic and translational skin science. The vision of the SDRC is: The ...

Findings from a new study could help doctors select more effective treatments earlier for patients suffering from leishmaniasis, a disfiguring skin infection.

US migrant populations experience various dermatologic conditions linked to exposures before, during, and after migration, ...

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.